Wednesday, July 08, 2009

U.S.: Medical Innovator; Europe: Free Rider

Most all the world pays a marginal cost for drugs, medical devices, and procedures that does not come close to repaying the development effort that went into those products. Further, most of the world has regimented medical systems that have very strong immune systems against any sort of innovation. As a result, almost all medical innovation occurs and is paid for in the United States, with the rest of the world acting as a free rider. Sure, some Swiss or Japanese firms still develop a few drugs, but most of those efforts are still justified by profits in the US market.

~Coyote Blog

The U.S. is still driving quite a bit of product innovation. Our messy, organic, wasteful, unfair, irrational system allows experimentation, and Europe cherry picks the best results. If we stopped doing this, their system would stop looking so good.

~Megan Mcardle


At 7/09/2009 10:15 AM, Anonymous Anonymous said...

But don't you see, that's the problem. If the U.S. would just stop developing new drugs and therapies that socialists only have to deny their sheeple access to, everyone would be either happy or dead. Progress creates inequality.

Everyone must be the same!
- Handicapper General, "Harrison Bergeron"

At 7/09/2009 11:04 AM, Anonymous Anonymous said...

You quoted McArdle. Do not pass go, do not collect your $200.

At 7/09/2009 12:03 PM, Anonymous Norman said...

If Congress was to pass a law on drugs I'd prefer one that mandated that drugs sold in the US be priced equal to or lower than the pricing in other countries. An elegant solution, I think.

At 7/09/2009 3:48 PM, Blogger ExtremeHobo said...

This comment has been removed by the author.

At 7/09/2009 3:49 PM, Blogger ExtremeHobo said...

Thankyou Anon 11:04,

I am actually now following McArdle's blog :-)

I had never heard of her until I read the silly hate-mongering blog you linked us to.


Post a Comment

<< Home